Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China · Delayed Price · Currency is CNY 16.60
+0.05 (0.30%)
Jan 23, 2026, 11:29 AM CST
SHA:688526 Market Cap
SHA:688526 has a market cap or net worth of 7.68 billion as of January 22, 2026. Its market cap has increased by 14.89% in one year.
Market Cap
7.68B
Enterprise Value
5.96B
Revenue
1.01B
Ranking
n/a
PE Ratio
16.90
Stock Price
16.60
Market Cap Chart
Since September 22, 2020, SHA:688526's market cap has decreased from 14.68B to 7.68B, a decrease of -47.72%. That is a compound annual growth rate of -11.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 7.68B | 8.45% |
| Dec 31, 2025 | 7.08B | 6.68% |
| Dec 31, 2024 | 6.64B | -30.15% |
| Dec 29, 2023 | 9.50B | -9.03% |
| Dec 30, 2022 | 10.44B | -18.45% |
| Dec 31, 2021 | 12.81B | -33.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Aidea Pharmaceutical Group | 8.84B |
| Daan Gene | 8.76B |
| Nanjing Vazyme Biotech | 8.56B |
| Shanghai Medicilon | 8.28B |
| Zhejiang Ausun Pharmaceutical | 8.16B |
| GemPharmatech | 7.52B |
| Suzhou Fengbei Biotech Stock | 7.25B |
| Jiangsu Bioperfectus Technologies | 7.12B |